You must log in to view this page.

Monte Rosa Therapeutics Inc. – Filings and Transcripts

NASDAQ: GLUE
Share price (3/27/26): $15.38
Market cap (3/27/26): $1.231 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

New Enterprise Associates 17, L.P.

News Filter

Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

Change in Directors, Officers or Compensation

Announces Pricing of $300 Million Underwritten Public Offering

Other Events, Financial Statements or Exhibits

Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness